Osteopenia Completed Phase 3 Trials for Zoledronic acid (DB00399)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00145275To Assess the Efficacy of Over-the-counter Analgesics in the Prevention/Treatment of Transient Post-dose Symptoms Following Zoledronate Infusion in Post-menopausal WomenTreatment
NCT00132808Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and OlderTreatment
NCT00798473Zoledronate for Osteopenia in Pediatric Crohn'sTreatment